Sponsor

NeurogesX

Clinical research sponsor

Published trials7
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

7 shown
Study of NGX-4010 for the Treatment of Painful HIV-Associated NeuropathyNCT00321672 · lead sponsor · 2006-06-01
COMPLETED
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)NCT00233155 · lead sponsor · 2005-08-01
COMPLETED
Study of NGX-4010 for the Treatment of Painful HIV-Associated NeuropathyNCT00064623 · lead sponsor · 2003-08-01
COMPLETED
Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainNCT00082316 · lead sponsor
COMPLETED
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainNCT00089557 · lead sponsor
TERMINATED
Study of NGX-4010 for Treatment of Painful HIV-Associated NeuropathyNCT00085761 · lead sponsor
TERMINATED
Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated NeuropathyNCT00061152 · lead sponsor
UNKNOWN

Sponsor roles

lead sponsor7

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.